Showing results (31-40 of 94) with videos related to
Sort By:
Pageof 10
Surgery|August 1, 1996
Active immunotherapy of pancreatic cancer with tumor cells genetically engineered to secrete multiple cytokinesB M Clary, E C Coveney, D G Blazer, et al.Clinical Lung Cancer|January 22, 2004
Gene therapy for lung cancerP J Mosca, M A Morse, T A D'Amico, et al.Cancer Research|January 19, 1999
Migration of human dendritic cells after injection in patients with metastatic malignanciesM A Morse, R E Coleman, G Akabani, et al.Current Opinion in Molecular Therapeutics|March 16, 2001
Monitoring cellular immune responses to cancer immunotherapyM A Morse, T M Clay, A C Hobeika, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Assays for monitoring cellular immune responses to active immunotherapy of cancerT M Clay, A C Hobeika, P J Mosca, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1987
Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attackH K Lyerly, T J Matthews, A J Langlois, et al.Critical Reviews in Immunology|October 20, 2001
Quantitating therapeutically relevant T-cell responses to cancer vaccinesA C Hobeika, T M Clay, P J Mosca, et al.Expert Opinion on Biological Therapy|December 1, 2001
Surrogate markers of response to cancer immunotherapyM A Morse, T M Clay, A C Hobeika, et al.Surgery|March 7, 2001
Direct detection of cellular immune responses to cancer vaccinesP J Mosca, A C Hobeika, T M Clay, et al.International Journal of Cancer|June 9, 1999
Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEAS K Nair, S Hull, D Coleman, et al.Pageof 10